查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
HIV/AIDS診斷的全球市場:成長，未來預測，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1180647

HIV/AIDS診斷的全球市場:成長，未來預測，競爭分析(2022年～2030年)

HIV/AIDS Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

HIV感染增加，HIV/AIDS的診斷和治療相關認識，早期診斷、治療、預防的研究開發的高漲，成為促進HIV/AIDS診斷市場的主要原因。

本報告提供全球HIV/AIDS診斷市場相關調查分析，市場趨勢，競爭分析，市場動態，各市場區隔、各地區的市場分析，企業簡介等系統性資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 HIV/AIDS診斷市場:競爭分析

  • 主要的HIV/AIDS診斷市場供應商的市場定位
  • HIV/AIDS診斷市場供應商採用的策略
  • 主要的產業策略
  • 階層分析:2021年對2030年

第4章 HIV/AIDS診斷市場:常量分析和市場動態

  • 簡介
  • 全球HIV/AIDS診斷市場價值(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要機會
  • 促進因素與阻礙因素的影響分析
  • See-Saw分析

第5章 HIV/AIDS診斷市場:各產品(2020年～2030年)

  • 市場概要
  • 成長、收益分析:2021年對2030年
  • 市場明細
    • 抗體檢驗
    • HIV-1抗體確認檢驗
    • 病毒鑑定檢驗
    • 病毒負擔試驗
    • CD4試驗
    • 幼兒的早期診斷

第6章 北美的HIV/AIDS診斷市場(2020年～2030年)

  • 市場概要
  • 各產品(2020年～2030年)
  • 各地區(2020年～2030年)
    • 北美

第7章 英國、EU的HIV/AIDS診斷市場(2020年～2030年)

  • 市場概要
  • 各產品(2020年～2030年)
  • 各地區(2020年～2030年)
    • 英國、EU

第8章 亞太地區的HIV/AIDS診斷市場(2020年～2030年)

  • 市場概要
  • 各產品(2020年～2030年)
  • 各地區(2020年～2030年)
    • 亞太地區

第9章 南美的HIV/AIDS診斷市場(2020年～2030年)

  • 市場概要
  • 各產品(2020年～2030年)
  • 各地區(2020年～2030年)
    • 南美

第10章 中東、非洲的HIV/AIDS診斷市場(2020年～2030年)

  • 市場概要
  • 各產品(2020年～2030年)
  • 各地區(2020年～2030年)
    • 中東、非洲

第11章 企業簡介

  • Abbott Laboratories
  • Abbvie Inc.
  • Alere Inc.
  • Apogee Flow Systems
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • BD Biosciences
  • Bio-Rad Laboratories
  • BioMerieux
  • Bristol-Myers Squibb
  • Cepheid
  • Chembio Diagnostics Systems
  • Daktari Diagnosticss
  • Gilead Sciences
  • Hologic Inc.
  • Merch & Co. Inc
  • Mylan Inc
  • Janssen Therapeutics
Product Code: 137518-08-22

According to WHO study, until now around 70 million people are infected with HIV virus and 35 million died of HIV infection. With rising mortality, the government and non-government institutes are taking initiatives and providing funding for diagnostic treatment and prevention of HIV/AIDS. With advancement of technology, novel diagnostic product are available in market which required minimum technical skills such as portable cell counter and point of care rapid diagnostic tests that fasten the diagnosis process. In developing countries such as India and China with growing population, rising awareness about HIV and emerging economies will be lucrative market for HIV/AIDS diagnostics. Increase in incidence of HIV infection, awareness about HIV/AIDs diagnosis and treatment, rising research and development for early diagnosis, treatment and prevention are key the factors driving the HIV/AIDS diagnostic market.

The report titled "HIV/AIDS Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall HIV/AIDS diagnostics market along with the market size and estimates for the duration 2020 to 2029. The said research study covers in-depth analysis of multiple market segments based on type of product and different geographies. The product type segment studied for analyzing the overall global HIV/AIDS diagnostics market is majorly segmented into antibody test, HIV-2 & Group O diagnostic Tests, viral load tests, CD4 testing, early infant diagnostics, viral identification testing.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global HIV/AIDS diagnostics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global HIV/AIDS diagnostics market. This report concludes with company profiles section that highlights major information about the key players engaged in global HIV/AIDS diagnostics market. In-depth competitive environment analysis and historical (2020) market size data are also provided in the report.

HIV/AIDS diagnostics market based on the type of products:

The most widely used test for detection of the HIV infection is antibody testing. Technological advancement in screening tests, rising incidence of HIV and growing awareness about blood donation, act as the major drivers of the antibody testing market. Rapid tests and ELISA form the major markets for the HIV diagnostic tests. With advances in technology, antibody confirmatory have become extremely accurate in giving end result, for example western blot test delivers 100% accuracy result screening post antibody test. Thus owing to high accuracy rate and increase in usage, antibody tests will continue to occupy dominant position in the forecast period. Monitoring tests such as viral load test, and CD4 testing are used to evaluate virologic load and assessment of the treatment safety, are anticipated to be the fastest growing market.

In 2021, North America dominated the global HIV/AIDS diagnostics market followed by the Europe. In North America region, U.S. occupies the maximum share of the market due to rise in prevalence of HIV infection, growing awareness programs and health care access, national funding for HIV affected people. Canada at regional level has different programs laid for treatment of AIDS, which further drives the diagnostic market in the country. Europe is the next important market driven by factors such as convenient access to health care facilities, high healthcare spending and introduction of novel treatment opportunities. Asia Pacific is anticipated to be fastest growing in HIV/AIDS diagnostic market in the forecast period. Developing countries contribute to rising number of HIV-AIDS population, and along with increase in government initiative for HIV diagnostic and treatment facilities, rising healthcare expenditure further drives the diagnostic market for Asia pacific.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of HIV/AIDS Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the HIV/AIDS Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Antibody Tests

HIV-1 Screening Tests

ELISA

Rapid Tests

Home Access Dried Blood Spots

HIV-1 Antibody Confirmatory Tests

Western Blot Tests

Indirect Immunofluorescence Assays (IFA)

Line Immunoassays

Radio-Immunoprecipitation Assays

Viral Identification testing

P24 Antigen

Qualitative PCR Test

Viral Culture

Viral Load Tests

CD4 Testing

Early Infant Diagnosticss

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of HIV/AIDS Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the HIV/AIDS Diagnostics market?

Which is the largest regional market for HIV/AIDS Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving HIV/AIDS Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the HIV/AIDS Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global HIV/AIDS Diagnostics Market
  • 2.2. Global HIV/AIDS Diagnostics Market, By Product, 2021 (US$ Million)
  • 2.3. Global HIV/AIDS Diagnostics Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. HIV/AIDS Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key HIV/AIDS Diagnostics Market Vendors
  • 3.2. Strategies Adopted by HIV/AIDS Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. HIV/AIDS Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global HIV/AIDS Diagnostics Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Antibody Tests
      • 5.3.1.1. HIV-1 Screening Tests
      • 5.3.1.2. ELISA
      • 5.3.1.3. Rapid Tests
      • 5.3.1.4. Home Access Dried Blood Spots
    • 5.3.2. HIV-1 Antibody Confirmatory Tests
      • 5.3.2.1. Western Blot Tests
      • 5.3.2.2. Indirect Immunofluorescence Assays (IFA)
      • 5.3.2.3. Line Immunoassays
      • 5.3.2.4. Radio-Immunoprecipitation Assays
    • 5.3.3. Viral Identification testing
      • 5.3.3.1. P24 Antigen
      • 5.3.3.2. Qualitative PCR Test
      • 5.3.3.3. Viral Culture
    • 5.3.4. Viral Load Tests
    • 5.3.5. CD4 Testing
    • 5.3.6. Early Infant Diagnosticss

6. North America HIV/AIDS Diagnostics Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 6.3.HIV/AIDS Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)

7. UK and European Union HIV/AIDS Diagnostics Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 7.3.HIV/AIDS Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)

8. Asia Pacific HIV/AIDS Diagnostics Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 8.3.HIV/AIDS Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)

9. Latin America HIV/AIDS Diagnostics Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 9.3.HIV/AIDS Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)

10. Middle East and Africa HIV/AIDS Diagnostics Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
  • 10.3.HIV/AIDS Diagnostics Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. HIV/AIDS Diagnostics Market: By Product, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Abbvie Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Alere Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Apogee Flow Systems
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Beckman Coulter, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Becton, Dickinson & Company
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. BD Biosciences
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Bio-Rad Laboratories
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. BioMerieux
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Bristol-Myers Squibb
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Cepheid
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. Chembio Diagnostics Systems
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives
  • 11.13. Daktari Diagnosticss
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Portfolio
    • 11.13.4. Strategic Initiatives
  • 11.14. Gilead Sciences
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Portfolio
    • 11.14.4. Strategic Initiatives
  • 11.15. Hologic Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Portfolio
    • 11.15.4. Strategic Initiatives
  • 11.16. Merch & Co. Inc
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Portfolio
    • 11.16.4. Strategic Initiatives
  • 11.17. Mylan Inc
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Portfolio
    • 11.17.4. Strategic Initiatives
  • 11.18. Janssen Therapeutics
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Portfolio
    • 11.18.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 3 Global HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 4 Global HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 5 North America HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 6 North America HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 7 North America HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 8 North America HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 9 U.S. HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 10 U.S. HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 11 U.S. HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 12 U.S. HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 13 Canada HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Canada HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 15 Canada HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 16 Canada HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 17 Rest of North America HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Rest of North America HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 19 Rest of North America HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 20 Rest of North America HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 21 UK and European Union HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 22 UK and European Union HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 23 UK and European Union HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 24 UK and European Union HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 25 UK HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 26 UK HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 27 UK HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 28 UK HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 29 Germany HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Germany HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 31 Germany HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 32 Germany HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 33 Spain HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 34 Spain HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 35 Spain HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 36 Spain HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 37 Italy HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Italy HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 39 Italy HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 40 Italy HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 41 France HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 42 France HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 43 France HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 44 France HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 45 Rest of Europe HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 46 Rest of Europe HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 47 Rest of Europe HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 48 Rest of Europe HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 49 Asia HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Asia HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 51 Asia HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 52 Asia HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 53 China HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 54 China HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 55 China HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 56 China HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 57 Japan HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 58 Japan HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 59 Japan HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 60 Japan HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 61 India HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 62 India HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 63 India HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 64 India HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 65 Australia HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 66 Australia HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 67 Australia HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 68 Australia HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 69 South Korea HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 70 South Korea HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 71 South Korea HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 72 South Korea HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 73 Latin America HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 74 Latin America HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 75 Latin America HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 76 Latin America HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 77 Brazil HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 78 Brazil HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 79 Brazil HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 80 Brazil HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 81 Mexico HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 82 Mexico HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 83 Mexico HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 84 Mexico HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 85 Rest of Latin America HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 86 Rest of Latin America HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 87 Rest of Latin America HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 88 Rest of Latin America HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 89 Middle East and Africa HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 90 Middle East and Africa HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 91 Middle East and Africa HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 92 Middle East and Africa HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 93 GCC HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 94 GCC HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 95 GCC HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 96 GCC HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 97 Africa HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 98 Africa HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 99 Africa HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 100 Africa HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)
  • TABLE 101 Rest of Middle East and Africa HIV/AIDS Diagnostics Market By Product, 2020-2030, USD (Million)
  • TABLE 102 Rest of Middle East and Africa HIV/AIDS Diagnostics Market By Antibody Tests, 2020-2030, USD (Million)
  • TABLE 103 Rest of Middle East and Africa HIV/AIDS Diagnostics Market By HIV-1 Antibody Confirmatory Tests, 2020-2030, USD (Million)
  • TABLE 104 Rest of Middle East and Africa HIV/AIDS Diagnostics Market By Viral Identification testing, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global HIV/AIDS Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global HIV/AIDS Diagnostics Market: Quality Assurance
  • FIG. 5 Global HIV/AIDS Diagnostics Market, By Product, 2021
  • FIG. 6 Global HIV/AIDS Diagnostics Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global HIV/AIDS Diagnostics Market, 2021
  • FIG. 8 Market Positioning of Key HIV/AIDS Diagnostics Market Players, 2021
  • FIG. 9 Global HIV/AIDS Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global HIV/AIDS Diagnostics Market, By Product, 2021 Vs 2030, %
  • FIG. 11 U.S. HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 14 UK HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 18 France HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 20 China HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 22 India HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa HIV/AIDS Diagnostics Market (US$ Million), 2020 - 2030